KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Short-term Investments (2016 - 2025)

Pacific Biosciences Of California has reported Short-term Investments over the past 16 years, most recently at $215.8 million for Q4 2025.

  • Quarterly results put Short-term Investments at $215.8 million for Q4 2025, down 35.5% from a year ago — trailing twelve months through Dec 2025 was $215.8 million (down 35.5% YoY), and the annual figure for FY2025 was $215.8 million, down 35.5%.
  • Short-term Investments for Q4 2025 was $215.8 million at Pacific Biosciences Of California, down from $242.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for PACB hit a ceiling of $684.6 million in Q2 2021 and a floor of $300000.0 in Q3 2023.
  • Median Short-term Investments over the past 5 years was $393.2 million (2024), compared with a mean of $352.3 million.
  • Peak annual rise in Short-term Investments hit 130955.0% in 2024, while the deepest fall reached 99.94% in 2024.
  • Pacific Biosciences Of California's Short-term Investments stood at $583.7 million in 2021, then fell by 23.38% to $447.2 million in 2022, then rose by 0.96% to $451.5 million in 2023, then decreased by 25.9% to $334.6 million in 2024, then plummeted by 35.5% to $215.8 million in 2025.
  • The last three reported values for Short-term Investments were $215.8 million (Q4 2025), $242.2 million (Q3 2025), and $259.9 million (Q2 2025) per Business Quant data.